Spark Newswire Spark Newswire
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
News by Category
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Asia
  • Asset Sales
  • Binary Options
  • Biotech
  • Bonds
  • Broad U.S. Equity ETFs
  • Buybacks
  • Cannabis
  • Commodities
  • Contracts
  • Crowdsourcing
  • Cryptocurrency
  • Currency ETFs
  • Dividends
  • Downgrades
  • Earnings
  • Earnings Beats
  • Earnings Misses
  • Econ #s
  • Economics
  • Education
  • Emerging Market ETFs
  • Emerging Markets
  • Entertainment
  • Entrepreneurship
  • Equities
  • ESG
  • ETFs
  • Eurozone
  • Events
  • Exclusives
  • FDA
  • Federal Reserve
  • Financial Advisors
  • Financing
  • Fintech
  • Forex
  • Futures
  • Gaming
  • General
  • Global
  • Government
  • Guidance
  • Health Care
  • Hedge Funds
  • Hot
  • Initiation
  • Insider Trades
  • Insurance
  • Interview
  • Intraday Update
  • IPOs
  • Large Cap
  • Latin America
  • Legal
  • Long Ideas
  • M&A
  • Macro Economic Events
  • Macro Notification
  • Management
  • Market Summary
  • Market-Moving Exclusives
  • Markets
  • Media
  • Mid Cap
  • Mining
  • Movers
  • Movers & Shakers
  • Mutual Funds
  • New ETFs
  • News
  • Offerings
  • Opinion
  • Options
  • Penny Stocks
  • Personal Finance
  • Politics
  • Pre-Market Outlook
  • Press Releases
  • Previews
  • Price Target
  • Psychedelics
  • Psychology
  • Real Estate
  • Regulations
  • REIT
  • Reiteration
  • Restaurants
  • Retail Sales
  • Reviews
  • Rumors
  • SEC
  • Sector ETFs
  • Short Ideas
  • Short Sellers
  • Signals
  • Small Business
  • Small Cap
  • Small Cap Analysis
  • Small-Cap
  • Social Media
  • SPACE
  • Specialty ETFs
  • Sports
  • Sports Betting
  • Startups
  • Stock Split
  • Success Stories
  • Tech
  • Technicals
  • Termination
  • Top Stories
  • Topics
  • Trading Ideas
  • Travel
  • Treasuries
  • Uncategorized
  • Upgrades
Spark Newswire Spark Newswire
Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.
  • Newswire
  • News
    • Guidance
    • Dividends
    • M&A
    • Buybacks
    • Legal
    • Interviews
    • Management
    • Offerings
    • IPOs
    • Insider Trades
    • Biotech/FDA
    • Tech
  • Markets
    • After Hours
    • Movers
    • ETFs
    • Forex
    • Commodities
    • Options
    • Binary Options
    • Bonds
    • Futures
    • Global Economics
    • Reviews
    • Small-Cap
    • Cryptocurrency
    • Penny Stocks
  • Analysts
    • Analyst Color
    • Analyst Ratings
    • Upgrades
    • Downgrades
  • Earnings
    • Earnings
  • Support & Feedback
  • Registration Options
  • Log In
Spark Newswire Spark Newswire
Filter By Ticker
Search By Date To
Today | Yesterday | This week
Browsing Category

Price Target

Price Target

Group By Ticker
Sort By
Newest | Oldest
Read More
3 minute read
  • After-Hours Center
  • Analyst Color
  • Analyst Ratings
  • Cryptocurrency
  • Earnings
  • Markets
  • News
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas

Tesla Bitcoin Sale A Positive, But Can The Company Address The ‘Elephant In The Room?’: What 5 Analysts Are Saying

By Chris Katje
July 21, 4:19 PM
Electric vehicle leader Tesla Inc (NASDAQ: TSLA) reported second-quarter financial results after market close Wednesday.

BTC

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Upgrades

CSX’s Q2 Results Get Mixed Reaction From Analysts – Read More For Details

By Akanksha Bakshi
July 21, 3:46 PM
Analysts react to CSX Corp's (NASDAQ: CSX) Q2 results.

CSX

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • Biotech
  • General
  • Health Care
  • Large Cap
  • News
  • Price Target

With All Eyes On Lecanemab Read Out In Alzheimer’s, Uncertainty Overshadows Biogen’s Q2 Beat

By Vandana Singh
July 21, 3:44 PM
Yesterday, Biogen Inc (NASDAQ:BIIB) reported Q2 earnings. Needham writes that while operational performance looked good, uncertainty looms over the company’s growth potential. Lecanemab Phase…

BIIB

Read More
1 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Morgan Stanley Rates PayPal, Says Its Growth Dependent On E-Commerce Growth Normalization

By Anusuya Lahiri
July 21, 3:22 PM
Morgan Stanley analyst James Faucette thinks e-commerce growth probably needs to normalize before investors can turn positive on PayPal Holdings, Inc (NASDAQ: PYPL).

AFRM

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Analysts React To Qualtrics’ Q2 Results

By Anusuya Lahiri
July 21, 3:21 PM
Analysts continue to exude confidence in Qualtrics International Inc (NASDAQ:XM) with a hint of caution despite dismal Q3 guidance. JMP Securities analyst Patrick…

XM

Read More
1 minute read
  • Analyst Color
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Short Sellers

Generac Price Target Slashed By ~7% At Keybanc

By Akanksha Bakshi
July 21, 2:47 PM
Keybanc analyst Jeffrey D. Hammond lowered the price target on Generac Holdings Inc. (NYSE:GNRC) to $325 (an upside of 30%) from $350 while…

GNRC

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • Price Target
  • Tech
  • Top Stories
  • Trading Ideas
  • Upgrades

Why This Palantir Analyst Says Stock Is A ‘Unicorn’ That Could Double In 1 Year

By AJ Fabino
July 21, 2:17 PM
Palantir Technologies Inc (NYSE: PLTR) was initiated with a Strong Buy rating with a $20 price target Thursday from Raymond James, which called the software company a “cultural unicorn." Here's what you need to know. 

NFLX

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • General
  • News
  • Price Target
  • Reiteration

Analysts Cut Bath & Body Works’ Price Target Post Outlook Revision

By Shivani Kumaresan
July 21, 2:03 PM
Telsey Advisory Group analyst Dana Telsey reiterated Outperform rating on Bath & Body Works Inc (NYSE: BBWI) and lowered the price target to $40 from $60 (23% upside)

BBWI

Read More
2 minute read
  • Analyst Color
  • Analyst Ratings
  • Earnings
  • Gaming
  • General
  • Global
  • Movers
  • News
  • Price Target
  • Reiteration
  • Top Stories
  • Trading Ideas
  • Upgrades

Why These 2 Analysts Are Bullish On Las Vegas Sands Despite Huge Q2 Loss

By Priya Nigam
July 21, 1:28 PM
Las Vegas Sands Corp. (NYSE: LVS) reported a 10.3% decline in revenues to $1.05 billion for the second quarter.

LVS

Read More
2 minute read
  • Analyst Ratings
  • News
  • Price Target
  • Reiteration
  • Tech

Analysts Place Their Bets On Azure As Microsoft Braces To Report Q4 Results

By Anusuya Lahiri
July 21, 1:10 PM
Analysts dig Microsoft Corp (NASDAQ: MSFT), which looks to report its Q4 earnings on July 26.

MSFT

Posts pagination

Previous 1 … 2,009 2,010 2,011 … 2,160 Next
Free Newsletter subscribe

Stock Market Ideas & Analysis

Stay up-to-date with the same information professionals use.
Spark Newswire Spark Newswire
  • Newswire
  • Registration
  • Log In
  • Settings
  • Privacy Policy
  • Terms of Service
© 2021 Spark Newswire
All Rights Reserved.

All news is property of their respective owners. Terms of Service